Miyazawa M et al. |
Sex differences in the metabolism of (+)- and (-)-limonene enantiomers to carveol and perillyl alcohol derivatives by cytochrome p450 enzymes in rat liver microsomes. |
2002 |
Chem. Res. Toxicol. |
pmid:11800592
|
Clark SS et al. |
Antileukemia activity of perillyl alcohol (POH): uncoupling apoptosis from G0/G1 arrest suggests that the primary effect of POH on Bcr/Abl-transformed cells is to induce growth arrest. |
2002 |
Leukemia |
pmid:11840288
|
Shi W and Gould MN |
Induction of cytostasis in mammary carcinoma cells treated with the anticancer agent perillyl alcohol. |
2002 |
Carcinogenesis |
pmid:11756234
|
Bardon S et al. |
Monoterpenes inhibit proliferation of human colon cancer cells by modulating cell cycle-related protein expression. |
2002 |
Cancer Lett. |
pmid:12175534
|
Bailey HH et al. |
A phase II trial of daily perillyl alcohol in patients with advanced ovarian cancer: Eastern Cooperative Oncology Group Study E2E96. |
2002 |
Gynecol. Oncol. |
pmid:12051875
|
Teruszkin Balassiano I et al. |
Effects of perillyl alcohol in glial C6 cell line in vitro and anti-metastatic activity in chorioallantoic membrane model. |
2002 |
Int. J. Mol. Med. |
pmid:12430008
|
Meadows SM et al. |
Phase II trial of perillyl alcohol in patients with metastatic colorectal cancer. |
2002 |
Int J Gastrointest Cancer |
pmid:12794248
|
Miyazawa M et al. |
Metabolism of (+)- and (-)-limonenes to respective carveols and perillyl alcohols by CYP2C9 and CYP2C19 in human liver microsomes. |
2002 |
Drug Metab. Dispos. |
pmid:11950794
|
Lantry LE et al. |
Chemopreventive efficacy of promising farnesyltransferase inhibitors. |
2000 |
Exp. Lung Res. |
pmid:11195470
|
Wei X et al. |
Perillyl alcohol inhibits TCR-mediated [Ca(2+)](i) signaling, alters cell shape and motility, and induces apoptosis in T lymphocytes. |
2000 |
Cell. Immunol. |
pmid:10805968
|
Si MS and Imagawa DK |
Prenylation inhibitors to treat proliferative renal disease. |
2000 |
Lancet |
pmid:10791545
|
Boon PJ et al. |
Cytotoxicity and biotransformation of the anticancer drug perillyl alcohol in PC12 cells and in the rat. |
2000 |
Toxicol. Appl. Pharmacol. |
pmid:10936079
|
Hudes GR et al. |
Phase I pharmacokinetic trial of perillyl alcohol (NSC 641066) in patients with refractory solid malignancies. |
2000 |
Clin. Cancer Res. |
pmid:10955786
|
Löw-Baselli A et al. |
Failure to demonstrate chemoprevention by the monoterpene perillyl alcohol during early rat hepatocarcinogenesis: a cautionary note. |
2000 |
Carcinogenesis |
pmid:11023545
|
Unlu S et al. |
Perillyl alcohol, an inhibitor of geranylgeranyl transferase, induces apoptosis of immortalized human vascular smooth muscle cells in vitro. |
2000 |
J. Cardiovasc. Pharmacol. |
pmid:10672871
|
Ripple GH et al. |
Phase I clinical and pharmacokinetic study of perillyl alcohol administered four times a day. |
2000 |
Clin. Cancer Res. |
pmid:10690515
|
Crowell PL |
Prevention and therapy of cancer by dietary monoterpenes. |
1999 |
J. Nutr. |
pmid:10082788
|
Ariazi EA et al. |
Activation of the transforming growth factor beta signaling pathway and induction of cytostasis and apoptosis in mammary carcinomas treated with the anticancer agent perillyl alcohol. |
1999 |
Cancer Res. |
pmid:10213501
|
Zhang Z et al. |
Gas chromatographic-mass spectrometric analysis of perillyl alcohol and metabolites in plasma. |
1999 |
J. Chromatogr. B Biomed. Sci. Appl. |
pmid:10379660
|
Ripple GH and Wilding G |
Drug development in prostate cancer. |
1999 |
Semin. Oncol. |
pmid:10597732
|